Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Death_Metalon Oct 04, 2018 6:06pm

92 Views

Post# 28748172

RE:Jan. 2018 - ESOU18: Socio-economic Impact of BCG Shortage

bencro wrote: Impalaman ... Funny, I just met this morning my 78-years old neighbour that recently completed her 7 BCG instillations. She just heard about the BCG shortage and refered to a company in France.

I told her "I know what you're talking about. It's Sanofi and it's about BCG shortage. Sanofi announced back in 2016 that they would get out in 2018 of that BCG manufacturing process, leaving Merck as the sole manufacturer of BCG".

I was intrigued as to where my neighbourg took its source. I assumed this could have made the news days ago.

So I did a search minutes ago on "Sanofi bcg" but found nothing recent.

Interestingly, in that search, I found the following June 2018 paper in AUA journals:

Only time will tell.